Blood Levels of IL-10 May Be Biomarker of Disease Activity in SLE Patients

High levels of the anti-inflammatory cytokine IL-10 are associated with higher disease activity in patients with systemic lupus erythematosus (SLE), a finding that suggests  IL-10 can be a potential blood biomarker for SLE. The study, “Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus,” was published in the journal…

Researchers Reveal a Promising Therapeutic Control Mechanism for Inflammation

A study recently published in the journal Nature Immunology revealed a protein that is able to suppress inflammation in the body. The study is entitled “IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal…